Once a single peptide backbone had been shown to be capable of carrying agonist activity at two structurally related class B G-protein-coupled receptors, the obvious next question was whether a third could be added to the same scaffold without losing potency at the first two, and whether the resulting pharmacology behaved like the sum of its parts or like something else
Before initiating this treatment, you must consult your doctor if you have any health conditions or your ongoing medications
Recovery should be measured by function, strength, resilience, and return to activity, not only by symptom reduction
For patients interested in the cellular energy component, see our NAD+ Treatment Plan at Perfect B in Doral
Presented for research literature review only Mori KF et al
Systemic allergic reactions are more concerning and require immediate medical attention